ArticleSmall science2025
Comparative Viability and Functionality of Bio-Jetted and Threaded Human Umbilical Vein Endothelial Cells.
Article in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced functional biological assays are critical for interrogating a process and/or material(s). The chicken embryo chorioallantoic membrane (CAM-an alternative in vivo system) and the angiogenesis assays, are two such well-established biological assays. In these investigative studies, both these assays are employed, together with immunostaining for CD31, and a clinical readout, namely flow cytometry, to fully assess post-treated human umbilical vein endothelial cells exposed to both electric field and nonelectric field driven spraying and spinning approaches in comparison to controls. Both these categories of directly jetting or threading living cells have significant implications, from their ability to directly reconstruct living 3D complex architectures. Such architectures have a plethora of applications spanning tissue reconstruction, to their exploration as organoids, spheroids to other complex models, for drug discovery and development, screening, to many other fields, extending to evolving food industry. The studies carried out herein demonstrate post-treated cells are viable and are comparable to controls, as assessed via flow cytometry. Post-treated cells exhibited comparable angiogenic sprouting and formed microtubules as seen via both immunohistochemistry staining with CD31, and the angiogenic assay, similar to controls. Finally, post-processed cells, demonstrated their ability to form a microvasculature indistinguishable to controls, by way of the CAM assay. These results push forward these platform biotechniques, for their exploration in both the biomedical laboratory and clinic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.